Recruitment

Recruitment Status
Unknown status

Inclusion Criteria

Type 2 diabetes mellitus reasonably well controlled (HbA1c less than or equal to 58 mmol/mol) on diet therapy or metformin alone
Body mass index (BMI) 27-37 kg/m2
Not taking anti-diabetes medication other than metformin
...
Type 2 diabetes mellitus reasonably well controlled (HbA1c less than or equal to 58 mmol/mol) on diet therapy or metformin alone
Body mass index (BMI) 27-37 kg/m2
Not taking anti-diabetes medication other than metformin
Understand verbal and/or written explanation of the study requirements
Age 18-60 years old
Male

Exclusion Criteria

Primary muscle disorders
Anti-diabetes medication other than metformin
Active gastrointestinal or liver disease
...
Primary muscle disorders
Anti-diabetes medication other than metformin
Active gastrointestinal or liver disease
Renal impairment (eGFR <60 ml/min)
Active respiratory disease
Other medications that may affect glucose tolerance (e.g. corticosteroids), muscle metabolism, or safety (e.g. anticoagulants)
Any other conditions in addition to the above that the investigators consider may affect study measurements or safety
Active cardiovascular disease (current angina, myocardial infarct, or coronary artery surgery/angioplasty within 12 months)
Clotting dysfunction
Malignancy (excluding localised basal and squamous cell skin cancer)
Cerebrovascular disease
Neurological disease e.g. epilepsy, Parkinsons disease
Metabolic diseases (stable treated hypothyroidism allowed)

Summary

Conditions
Type 2 Diabetes
Type
Interventional
Phase
Phase 2
Design
  • Allocation: Randomized
  • Intervention Model: Parallel Assignment
  • Masking: Double (Participant, Investigator)
  • Primary Purpose: Basic Science

Participation Requirements

Age
Between 18 years and 60 years
Gender
Only males

Inclusion Criteria

Type 2 diabetes mellitus reasonably well controlled (HbA1c less than or equal to 58 mmol/mol) on diet therapy or metformin alone
Body mass index (BMI) 27-37 kg/m2
Not taking anti-diabetes medication other than metformin
...
Type 2 diabetes mellitus reasonably well controlled (HbA1c less than or equal to 58 mmol/mol) on diet therapy or metformin alone
Body mass index (BMI) 27-37 kg/m2
Not taking anti-diabetes medication other than metformin
Understand verbal and/or written explanation of the study requirements
Age 18-60 years old
Male

Exclusion Criteria

Primary muscle disorders
Anti-diabetes medication other than metformin
Active gastrointestinal or liver disease
...
Primary muscle disorders
Anti-diabetes medication other than metformin
Active gastrointestinal or liver disease
Renal impairment (eGFR <60 ml/min)
Active respiratory disease
Other medications that may affect glucose tolerance (e.g. corticosteroids), muscle metabolism, or safety (e.g. anticoagulants)
Any other conditions in addition to the above that the investigators consider may affect study measurements or safety
Active cardiovascular disease (current angina, myocardial infarct, or coronary artery surgery/angioplasty within 12 months)
Clotting dysfunction
Malignancy (excluding localised basal and squamous cell skin cancer)
Cerebrovascular disease
Neurological disease e.g. epilepsy, Parkinsons disease
Metabolic diseases (stable treated hypothyroidism allowed)

Tracking Information

NCT #
NCT02197299
Collaborators
Not Provided
Investigators
  • Principal Investigator: Francis B Stephens, PhD The University of Nottingham
  • Francis B Stephens, PhD The University of Nottingham
About Us
Innovation
Privacy
Terms
Copyright
Get Well Soon © Copyright 2024